7Koren M J, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991 ;114:345-352.
8Takemono M, Node K, Nakagami H. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 2001 ;108: 1429-1437.
9Ye P, Sheng L, Zhang C, Liu Y. Atorvastatin attenuating down-regulation of peroxisome proliferator-activated receptor gamma in preventing cardiac hypertrophy of rats in vitro and in vivo. J Pharm Pharm Sci 2006:9 : 365-375.
10World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO), International Society of Hypertension (ISH) statement on management of hypertension (Guidelines and recommendations). J Hypertens 2003;21: 1983-1992.
